ISCOM vaccines MCQs With Answer

Introduction:
ISCOM (Immunostimulating Complex) vaccines are an advanced adjuvant platform that combines saponin (commonly Quil A or QS-21), cholesterol and phospholipid to form cage-like particles that efficiently deliver antigen and stimulate robust immune responses. For M.Pharm students, understanding ISCOMs is important because they uniquely promote both strong humoral and cellular immunity, enable antigen dose-sparing, and facilitate cross-presentation for cytotoxic T-cell induction. This quiz set explores composition, preparation, mechanisms of action, antigen incorporation strategies, safety considerations, and comparative advantages of ISCOMs versus other delivery systems—key areas required for vaccine design, regulatory assessment, and translational research in immunotechnology.

Q1. What are the core structural components of a classical ISCOM particle?

• Quil A (saponin), cholesterol, phospholipid
• Polysaccharide, aluminum hydroxide, protein
• Lipid A, DNA plasmid, polyethylene glycol
• Chitosan, mannose, alginate

Correct Answer: Quil A (saponin), cholesterol, phospholipid

Q2. Which saponin fraction is preferred for human clinical use due to improved safety compared to crude Quil A?

• QS-21
• Quil T
• Ginsenoside Rg1
• Saponin A1

Correct Answer: QS-21

Q3. What is the typical approximate particle size of ISCOMs that contributes to efficient lymphatic uptake and APC interaction?

• ~40 nm
• ~5 µm
• ~200 nm
• ~1 mm

Correct Answer: ~40 nm

Q4. How do ISCOMs primarily enhance induction of CD8+ cytotoxic T lymphocyte responses?

• By promoting cross-presentation of antigen via MHC class I on dendritic cells
• By directly fusing with T cells and delivering antigen into the nucleus
• By acting as a depot for slow antigen release only
• By inhibiting antigen processing to preserve native proteins

Correct Answer: By promoting cross-presentation of antigen via MHC class I on dendritic cells

Q5. Which statement best distinguishes ISCOMATRIX from an ISCOM?

• ISCOMATRIX contains the adjuvant cage (saponin/cholesterol/phospholipid) but no antigen incorporated, whereas ISCOM has antigen integrated into the particle
• ISCOMATRIX is a liposome with entrapped antigen, ISCOM is a polymer nanoparticle
• ISCOMATRIX uses aluminum salts, ISCOM uses squalene oil-in-water emulsion
• ISCOMATRIX is an oral formulation, ISCOM is an intranasal spray

Correct Answer: ISCOMATRIX contains the adjuvant cage (saponin/cholesterol/phospholipid) but no antigen incorporated, whereas ISCOM has antigen integrated into the particle

Q6. Which antigen type is most readily incorporated into classical ISCOMs without additional modification?

• Membrane-associated glycoproteins or lipid-anchored antigens
• Small hydrophilic peptides lacking lipid moieties
• High molecular weight polysaccharides only
• Plasmid DNA without any carrier

Correct Answer: Membrane-associated glycoproteins or lipid-anchored antigens

Q7. Which preparation strategy is commonly used to assemble ISCOMs by removing detergent from a mixed micelle solution?

• Dialysis
• Sublimation
• Spray drying
• Sonication without detergent

Correct Answer: Dialysis

Q8. ISCOMs are known to bias antibody subclass switching in mice toward which subclass associated with Th1 responses?

• IgG2a
• IgG1
• IgM
• IgA

Correct Answer: IgG2a

Q9. Which of the following is a major safety concern with crude Quil A that led to the development of purified fractions?

• Hemolytic and reactogenic effects at higher doses
• Complete loss of adjuvanticity
• Incompatibility with lipids leading to precipitation
• Induction of tolerance instead of immunity

Correct Answer: Hemolytic and reactogenic effects at higher doses

Q10. Compared to alum adjuvants, ISCOMs typically provide which immunological advantage?

• Stronger induction of cellular (CTL) responses as well as humoral immunity
• Exclusive induction of Th2-type humoral responses only
• Longer antigen retention at the injection site with no systemic spread
• Better compatibility for oral administration in pill form

Correct Answer: Stronger induction of cellular (CTL) responses as well as humoral immunity

Q11. What is a common analytical method used to characterize ISCOM particle size and homogeneity during development?

• Dynamic light scattering (DLS)
• Thin layer chromatography (TLC)
• Northern blotting
• Ion exchange chromatography

Correct Answer: Dynamic light scattering (DLS)

Q12. Why can ISCOMs achieve antigen dose-sparing compared to soluble antigen formulations?

• They enhance antigen uptake and presentation to APCs, increasing immune efficiency
• They chemically modify antigens to increase molecular weight
• They block antigen degradation permanently, preventing catabolism
• They neutralize host antibodies to allow repeated higher dosing

Correct Answer: They enhance antigen uptake and presentation to APCs, increasing immune efficiency

Q13. Which regulatory consideration is particularly important for ISCOM-based vaccines during clinical translation?

• Characterization and consistency of saponin fractions (e.g., QS-21) and manufacturing reproducibility
• Ability to completely avoid cold chain requirements for all ISCOMs
• Demonstration that ISCOMs are effective by oral administration only
• Proof that ISCOMs integrate into host DNA safely

Correct Answer: Characterization and consistency of saponin fractions (e.g., QS-21) and manufacturing reproducibility

Q14. Which immune cells are primary targets for ISCOM uptake and antigen presentation leading to adaptive responses?

• Dendritic cells
• Red blood cells
• Hepatocytes
• Osteoclasts

Correct Answer: Dendritic cells

Q15. Which in vitro assay would best demonstrate ISCOM-induced cross-presentation to CD8+ T cells?

• Co-culture of antigen-pulsed dendritic cells with antigen-specific CD8+ T cells and measurement of IFN-γ release
• Hemagglutination inhibition assay
• Gram staining of ISCOM preparations
• Bradford protein assay for total protein content

Correct Answer: Co-culture of antigen-pulsed dendritic cells with antigen-specific CD8+ T cells and measurement of IFN-γ release

Q16. When incorporating a soluble protein antigen that does not naturally associate with lipids into an ISCOM, which strategy is commonly used?

• Chemically lipidating the antigen or using a carrier that anchors it into the lipid matrix
• Heating the protein to 100°C to enhance hydrophobicity
• Adding excess polysorbate to prevent incorporation
• Encapsulating antigen in alginate beads separately

Correct Answer: Chemically lipidating the antigen or using a carrier that anchors it into the lipid matrix

Q17. Which statement describes an advantage of ISCOMs over traditional oil-in-water emulsions?

• ISCOMs can elicit stronger cellular immunity and cross-presentation with lower systemic reactogenicity when optimized
• ISCOMs rely exclusively on a depot effect and are therefore slower to act
• ISCOMs are easier to produce at large scale without controlling saponin quality
• ISCOMs are ineffective at inducing mucosal IgA compared to emulsions

Correct Answer: ISCOMs can elicit stronger cellular immunity and cross-presentation with lower systemic reactogenicity when optimized

Q18. Which purification technique is commonly applied to separate assembled ISCOM particles from free saponin and detergent remnants?

• Density gradient ultracentrifugation
• Affinity chromatography against albumin
• Electrophoretic transfer to nitrocellulose
• Size-exclusion HPLC using 0.01 µm filters only

Correct Answer: Density gradient ultracentrifugation

Q19. In preclinical models, which route of administration has typically been used for ISCOM and ISCOMATRIX vaccine candidates to generate systemic immunity?

• Subcutaneous or intramuscular injection
• Oral capsule administration
• Topical application to intact skin
• Inhalation aerosol without formulation changes

Correct Answer: Subcutaneous or intramuscular injection

Q20. Which mechanistic feature explains why ISCOMs can promote balanced Th1/Th2 responses rather than a strictly Th2-biased response?

• Saponin-mediated activation of innate immune pathways and efficient antigen delivery to dendritic cells enabling both MHC I and MHC II presentation
• Exclusive activation of B cells without engaging antigen-presenting cells
• Complete suppression of innate cytokine production to avoid inflammation
• Immediate degradation of antigen into single amino acids

Correct Answer: Saponin-mediated activation of innate immune pathways and efficient antigen delivery to dendritic cells enabling both MHC I and MHC II presentation

Download